Showing results (1531-1540 of 1,553) with videos related to
Sort By:
Pageof 156
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2025
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON StudyJin-Ji Yang, Yu Mu, Zhe-Hai Wang, et al.Ebiomedicine|September 14, 2023
A multicenter prospective study of comprehensive metagenomic and transcriptomic signatures for predicting outcomes of patients with severe community-acquired pneumoniaJingya Zhao, Xiangyan He, Jiumeng Min, et al.The Lancet. Respiratory Medicine|December 15, 2023
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trialMengzhao Wang, Yun Fan, Meili Sun, et al.Med (New York, N.Y.)|October 10, 2024
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trialQing Zhou, Yan Yu, Ligang Xing, et al.Blood Advances|July 20, 2021
A polygenic score for acute vaso-occlusive pain in pediatric sickle cell diseaseEvadnie Rampersaud, Guolian Kang, Lance E Palmer, et al.Lung Cancer (Amsterdam, Netherlands)|June 28, 2020
A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA studyShun Lu, Gongyan Chen, Yuping Sun, et al.Nature Medicine|January 6, 2025
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trialYuankai Shi, Jian Fang, Ligang Xing, et al.JAMA Network Open|May 4, 2019
Assessment of Molecular Subtypes in Thyrotoxic Periodic Paralysis and Graves Disease Among Chinese Han Adults: A Population-Based Genome-Wide Association StudyShuang-Xia Zhao, Wei Liu, Jun Liang, et al.Cell Reports. Medicine|May 7, 2025
Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutationYan Xu, James Chih-Hsin Yang, Yanqiu Zhao, et al.ACS Nano|August 22, 2025
Roadmap for Next-Generation Electrochemical Energy Storage Technologies: Secondary Batteries and SupercapacitorsYu Yao, Xianhong Rui, Ruilin Bai, et al.Pageof 156